BlackRock acquired 2.47M LB PharmaceuticalsCommon Stock shares worth $71.4M. That's 0.00% of their equity portfolio (2218th largest holding). The investor owns 8.90% of the outstanding LB PharmaceuticalsCommon Stock stock. The stake costed the investor $48.5M, netting the investor a gain of 47% so far.